Clinical Trials Browser

Phase 1/2 × Leiomyosarcoma × Gemcitabine × Clear all

NCT06498648 2026-03-19

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Phase 1/2 Recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma